Item 5. Market for Registrant’s Common Equity
ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock currently is traded on the NASDAQ Stock Market LLC. As of March 15, 2022, we had approximately 600 stockholders of record. Since many stockholders choose to hold their shares under the name of their brokerage firm, we estimate that the actual number of stockholders was over 3,500 stockholders.
Securities Authorized for Issuance Under Equity Compensation Plans
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
(a) Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
(b) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a))
(c)
Equity compensation plans approved by security holders 5,337,691 $ 5.97 3,130,915
Equity compensation plans not approved by security holders (1)
60,000 $ 4.18 —
Total 5,397,691 $ 5.95 3,130,915
(1) Represents inducement grants for new hires
Dividend Policy
We have never declared or paid any cash dividends on our common stock and we currently do not anticipate paying cash dividends in the foreseeable future. We currently expect to retain any future earnings to fund the operation and expansion of our business.
20
Table of Contents
APYX MEDICAL CORPORATION
Five Year Performance Graph
The following line graph compares the cumulative total return of our common shares with the cumulative total return of the Russell 2000 Stock Index and the Russell 3000 Stock Index. The line graph assumes, in each case, an initial investment of $100 on December 31, 2017, based on the market prices at the end of each fiscal year through and including December 31, 2021, and reinvestment of dividends.
December 31,
2017 2018 2019 2020 2021
Apyx Medical Corporation 100.00 249.23 325.38 276.92 493.07
Russell 2000 Index 100.00 87.82 108.65 128.6 146.21
Russell 3000 Index 100.00 93.01 119.55 141.38 176.15
21
Table of Contents
APYX MEDICAL CORPORATION
ITEM 6. Reserved
22
Table of Contents
APYX MEDICAL CORPORATION
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.